In multiple myeloma, MAP3K8 activation promoted the acquisition of the M2 macrophage phenotype that promotes immunosuppression and inflammation (Hope et al., 2014; Jensen et al., 2015). The gene discussed is MAP3K8; the disease is plasma cell myeloma.